ALSO READIndrayani Biotech reports standalone net loss of Rs 0.02 crore in the March 2017 quarter Indrayani Biotech to announce Quarterly Result BSE revises circuit limit of six firms Titan Biotech standalone net profit rises 6.52% in the June 2017 quarter Medicamen Biotech standalone net profit declines 36.81% in the March 2017 quarter
Reported sales nilNet Loss of Indrayani Biotech reported to Rs 0.04 crore in the quarter ended June 2017 as against net loss of Rs 0.04 crore during the previous quarter ended June 2016. There were no Sales reported in the quarter ended June 2017 and during the previous quarter ended June 2016.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)